26-27 February 2018

Global NASH Congress 2018

London, United Kingdom

The Global NASH Congress of 2018 is a comprehensive two-day summit that attracts experts working across all areas of non-alcoholic steatohepatitis, with the conference examining the latest research and development in pathogenesis, diagnosis, and treatment methods.

The NASH conference will feature over 40 expert-led presentations, interactive panel and roundtable discussions exploring key issues, and an exhibition room filled with technology providers showcasing relevant solutions. Featured topics at the event include molecular heterogeneity of NAFLDs in humans; lifestyle intervention; and a case study on autotaxin as a potential drug target for NASH.

The Resonance Health team of Melanie Baxter, and Dr Susanna Katay-Davies will be attending this two day event to promote HepaFat-Scan and the Company’s other service offerings in the fields of NASH and NAFLD.